Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

First Cobalt Starts Study to Enhance Refinery Economics & Invests in eCobalt Solutions

The Cobalt price continues to languish below US$20/lb. This is an unexpected development given that last year the price was at or > $40/lb. for much of March, April & May. In speaking with experts and reading industry analysis, the consensus is that the Cobalt price could sett...
Peter Epstein | May 8, 2019 |

Meet the Company Diving into the Cannabis 3.0 Market

The first and second waves of the cannabis market have come and gone, which has only prepared us for the cannabis 3.0 market and all the derivative products that come with it. Companies like Ayurcann Holdings Corp. ( CSE:AYUR , OTCQB:AYURF , Forum ) are...
Jocelyn Aspa | March 23, 2022 |

Paratek Pharma Awarded $285 Million BARDA Contract to Combat Anthrax

Shares of Paratek Pharmaceuticals traded 40% higher today after the firm announced it was awarded a BARDA BioShield program contract valued at up to $285 million for NUZYRA used to treat anthrax. Late yesterday afternoon, biopharmaceutical company Paratek Pharmaceuti...
Streetwise Reports | December 20, 2019 |

Fintech Payment Solutions Provided…Seamlessly

In mid-July , our Stockhouse audience was introduced to a fintech company with a very unique business model that’s created a secure, easy-to-use payment solution for the student market – Euro Asia Pay Holdings Inc. (EAP) ( CSE.EAP , Forum ). St...
Dave Jackson | September 21, 2021 |

A True Disruptive Technology that Leverages the Power of Analytics

When Stockhouse Editorial first introduced our audience to Visionstate Corp. ( TSX-V: VIS , OTC: VSSSF , Forum ) back in May , we learned about a company so unique that their Internet of Things platform has, essentially, no direct competition in the marketplace. Vision...
Dave Jackson | January 14, 2022 |

Axsome Therapeutics Investors Awaken to Positive Outcome in Phase 2 Narcolepsy Trial

Axsome Therapeutics shares traded 14% higher today after the company reported that its narcolepsy drug candidate AXS-12 achieved its primary endpoint in the Phase 2 CONCERT Study. This morning before U.S. markets opened, clinical-stage biopharmaceutical company Axsom...
Streetwise Reports | December 4, 2019 |

Novavax Shares Rise 9% Upon Initiating Phase 1/2 COVID-19 Vaccine Clinical Trial

Novavax shares traded higher after the company reported it enrolled the first participants in its Phase 1 clinical study of NVX CoV2373. Novavax Inc. (NVAX:NASDAQ) , which focuses its efforts on developing next-generation vaccines to address infectious diseases, ye...
Streetwise Reports | May 27, 2020 |

Buzz on the Bullboards: Summer's most talked about stocks

August has been a rough month for North American stock markets, with red days and a lot of flat trading activity. Shares of U.S. banks fell this week after several regional lenders were hit with a credit downgrade. Retailers are stuck with products that aren&CloseCurl...
Jonathon Brown | August 24, 2023 |

Star Navigation explains share lock up and gives update on sales activity

Star Navigation continues to make gains with its proprietary navigational technology, tracking performance trends and predicting incident occurrences. The Toronto-based company continues to attract clients in the public and private sector, looking to increase safety a...
Simon Druker | April 14, 2023 |

Led by Sales of HETLIOZ, Vanda Increases Quarterly Revenues by 25%

Shares of Vanda Pharmaceuticals traded nearly 30% higher after the company released Q2/19 earnings and positive sales trends for both HETLIOZ and Fanapt. Biopharmaceutical maker Vanda Pharmaceuticals Inc. (VNDA:NASDAQ) yesterday announced financial and ...
Streetwise Reports | August 6, 2019 |
1 2 3 4 5 6 7 8 9 10 ...